Intrathecal cytomegalovirus immunoglobulin for CMV encephalitis post allogeneic stem cell transplantation

We report the outcome of a 43 year old man who developed fatal ventriculoencephalitis due to cytomegalovirus (CMV) infection 7 months post allogeneic stem cell transplant. He failed multiple lines of treatment, including intravenous ganciclovir, foscarnet, and CMV-specific immunoglobulins, without i...

Full description

Bibliographic Details
Main Authors: Ian Pang, Sanjay Singhabahu, Igor Novitzky-Basso, Tony Mazzulli, Shahid Husain, Jonas Mattsson
Format: Article
Language:English
Published: Elsevier 2022-01-01
Series:IDCases
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2214250922002360